Dear Dr. Roach: In a recent column, you wrote about reducing cholesterol with the help of statins along with a PCSK9i, such as Repatha or Praluent. My question is: Are these PCSK9is at all beneficial ...

SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...

Statins have revolutionized heart disease by lowering cholesterol effectively—by up to 50% or more. But anywhere from 7% to 29% of people who take them may be more susceptible to its side effects, ...

Dear Dr. Roach: In a recent column, you wrote about reducing cholesterol with the help of statins along with a PCSK9i, such as Repatha or Praluent. My question is: Are these PCSK9is at all beneficial ...

Monotherapy with inclisiran — an injectable small interfering RNA that targets hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) — reduced levels of low-density lipoprotein (LDL) ...

The newer statins on the market have longer half-lives than the original statins. Alternative dosing schedules using once-, twice- or three-times a week or every-other-day dosing, have been ...

High cholesterol doesn't come with symptoms, but it can still be a serious risk to your health. Cholesterol-lowering drugs ...

Those who took bempedoic acid once a day had on average a 30.2 mg/dL or 21.3% reduction in low-density lipoprotein (LDL) cholesterol levels over about a three-year period. Elevated LDL levels can lead ...

A one-off shot of a new drug could cut high cholesterol levels for life. The ‘game-changing’ drug, currently known as VERVE-102, works by switching off a gene involved in the production of so-called ...